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Abstract
Introduction: There is limited evidence on the impact of centralization of cancer 
treatment services on patient travel burden and access to treatment. Using prostate 
cancer surgery as an example, this national study analysis aims to simulate the effect 
of different centralization scenarios on the number of center closures, patient travel 
times, and equity in access.
Methods: We used patient-level data on all men (n = 19,256) undergoing radical 
prostatectomy in the English National Health Service between January 1, 2010 and 
December 31, 2014, and considered three scenarios for centralization of prostate 
cancer surgery services A: procedure volume, B: availability of specialized services, 
and C: optimization of capacity. The probability of patients travelling to each of the 
remaining centers in the choice set was predicted using a conditional logit model, 
based on preferences revealed through actual hospital selections. Multivariable linear 
regression analysed the impact on travel time according to patient characteristics.
Results: Scenarios A, B, and C resulted in the closure of 28, 24, and 37 of the 65 radi-
cal prostatectomy centers, respectively, affecting 3993 (21%), 5763 (30%), and 7896 
(41%) of the men in the study. Despite similar numbers of center closures the expected 
average increase on travel time was very different for scenario B (+15 minutes) and 
A (+28 minutes). A distance minimization approach, assigning patients to their next 
nearest center, with patient preferences not considered, estimated a lower impact on 
travel burden in all scenarios. The additional travel burden on older, sicker, less afflu-
ent patients was evident, but where significant, the absolute difference was very small.
Conclusion: The study provides an innovative simulation approach using national 
patient-level datasets, patient preferences based on actual hospital selections, and 
personal characteristics to inform health service planning. With this approach, we 
demonstrated for prostate cancer surgery that three different centralization scenarios 
2 |   AGGARWAL et AL.
1 |  INTRODUCTION
The centralization of complex cancer surgery into high-vol-
ume units is occurring in most high-income countries as a 
consequence of a range of policies aiming to improve the qual-
ity and efficiency of cancer services.1-3 This has been in re-
sponse to studies from predominantly Europe and the United 
States identifying improved outcomes of care for patients 
treated by specialized and experienced teams at centers per-
forming a high volume of surgical procedures,4,5 particularly 
for more complex surgery such as pancreatic, esophageal, and 
prostate cancers. Prostate cancer is a relevant tumor type when 
considering the centralization of specialist services. First, the 
quality of the surgery has an impact on the chance of complete 
removal of the tumor whilst minimizing the risk of side ef-
fects, such as urinary incontinence and erectile dysfunction.6 
Second, a volume outcome relationship has been established 
for different end-points following prostate cancer surgery.7
In light of this, national cancer plans in the English 
National Health Service (NHS) have since 2002 advocated 
the centralization of specialist urological surgical services 
into fewer, high-volume centers. The NHS provides treatment 
to more than 90% of cancer patients.8 A new geographical 
configuration was established, with local cancer units refer-
ring patients suitable for a radical prostatectomy to a regional 
specialist center.9,10 However, a consequence of centraliza-
tion is that it may require patients to travel further for treat-
ment which could widen inequities in access for those less 
able to travel.11,12
This is relevant considering a previous analysis for pros-
tate cancer surgery which found that patterns of patient mobil-
ity has resulted in shifts in hospitals’ market shares.13 One in 
three men who had a radical prostatectomy for prostate cancer 
between 2010 and 2014 in the English NHS travelled beyond 
or bypassed their nearest prostate cancer surgery center. Men 
who were younger, fitter, and more affluent were more likely 
to travel to another surgery center than the one nearest to them.
This highlights concerns with respect to the increas-
ing regionalization of specialist services. For example, 
increased travel times for cancer care could reduce treat-
ment uptake for specific patient groups. This is particu-
larly relevant for prostate cancer where competing radical 
treatment strategies exist (eg surgery, radiotherapy, and 
brachytherapy), which are often located at different geo-
graphic locations.14,15 In addition, apparent advantages of 
the volume-outcome relationship that may emerge from 
centralization of care may not be shared equally across 
the population, but instead concentrated in patients best 
able to access the benefit of centralization. Those patients 
are likely to be closer to high performing centers, or else 
younger, fitter, and more affluent.
1.1 | Centralization of prostate cancer 
services in the NHS
Since 2010, 15 of 65 functioning prostate cancer surgery 
centers have been closed in the English NHS due to a com-
bination of regional coordination between specialist cent-
ers as well as the effects of hospital competition and patient 
choice, partly driven by the adoption of robotic surgery.16 
The integration of robotic surgery as a driver of centraliza-
tion of prostate cancer surgery has been observed in several 
countries.17-19
The result of centralization on patient travel burden and 
treatment quality remains unknown, but it does highlight the 
need for a robust evidence-based approach to health service 
planning. An important question is to what extent changes in 
the configuration of specialist services have a negative im-
pact on the ability of all patients to access centralized special-
ist services which could lead to unintended consequences on 
patient outcomes.20
A recent study has used discrete choice experiments 
within small samples of patients, health professionals and the 
general public to get a better understanding of the accept-
ability of different centralization scenarios, focusing on the 
trade-off between travel time and treatment outcomes for 
cancer surgery.21 The willingness to travel found by this study 
seems improbably large. It was estimated that people are will-
ing to travel 75 minutes extra for a 1% lower absolute risk of 
complications and even more than 5  hours extra to reduce 
their risk of death by 1%. The extent to which these “stated” 
preferences can be used as a means of informing policy is 
debatable because responses to hypothetical scenarios and 
patients’ preferences “revealed” through their actual behavior 
may be different.22-24
There is an increasing body of literature that has attempted 
to simulate the effect of centralization of health care services 
based on parameters derived from population-level adminis-
trative hospital data on actual patient visits. Previous studies 
would lead to similar number of center closures but to different increases in patient 
travel time, whilst all having a minimal impact on equity.
K E Y W O R D S
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attempting to assess the impact of centralization on travel 
times have followed the “distance minimization approach,” 
simply diverting patients who were treated at a center that is 
closed (as per the centralization scenario) to the nearest alter-
native center that would be still open after centralization.11,25 
An approach which only values distance or spatial access 
fails to acknowledge the significant number of other factors 
that account for patient preference for treatment center. Based 
on revealed preferences derived from studies of actual travel 
patterns, it is known that patients are prepared to travel be-
yond (bypass) their nearest hospital for treatment,26,27 for 
example in response to the reputation of hospitals and their 
surgeons, the availability of innovative technologies, and 
waiting time.28
In this present study, we use data on actual travel patterns 
and an innovative simulation approach to provide a robust 
and comprehensive assessment of the impacts of three hypo-
thetical re-design scenarios on travel time and equity in ac-
cess to radical prostatectomy services in the English NHS, a 
single-payer system. Our simulation approach, however, can 
be applied by any authority, public or private, that is seeking 
to rationalize its health services into fewer centers nationally 
or regionally or within particular insurer catchment areas.
2 |  METHODS
2.1 | Data sources and study population
For this study, we obtained individual patient-level data on 
all men who were diagnosed with prostate cancer and un-
derwent radical prostatectomy in the English NHS between 
January 1, 2010 and December 31, 2014 from the Hospital 
Episode Statistics (HES) database linked at the patient-level 
to English cancer registry data. These data provide informa-
tion on where patients actually received the treatment.
The population-weighted centroids of the patients’ Lower 
Super Output Areas (geographic areas defined by the Office 
for National Statistics that typically includes 1500 residents 
or 650 households) and the full postcodes for the hospitals 
where the surgery was undertaken were inputted into a geo-
graphical information system (ESRI ArcGIS 10.3) to calcu-
late travel times according to the fastest route by car (using 
Ordnance Survey MasterMap Integrated Transport Network). 
For each patient, the travel time to all prostate cancer surgical 
centers was calculated.
The HES dataset was used to determine patient-level 
characteristics, including age, the number of comorbidities 
according to the Royal College of Surgeons Charlson comor-
bidity score,29 socioeconomic deprivation expressed in terms 
of quintiles of national distribution of the Index of Multiple 
Deprivation,30 hospital that provided the surgical treatment, 
and date of the surgical procedure. National cancer registry 
data were used as the data source for cancer stage, which was 
categorized according to a modified D’Amico classification 
system.31,32
2.2 | Centralization scenarios
For the purpose of our study, we created three pragmatic 
centralization scenarios to identify hypothetical closures of 
surgical units based on current clinical and policy discussion 
regarding quality improvement, patient experience, and ef-
ficient use of NHS resources.
In Scenario A (volume), surgical treatment for prostate 
cancer is restricted to centers undertaking more than 50 rad-
ical prostatectomies per annum. This scenario follows evi-
dence supporting improvements in peri- and postoperative 
outcomes as well as function when surgery is performed in 
high-volume relative to low-volume units. The threshold of 
50 procedures is based on current guidelines and the volume 
outcome literature.7
In Scenario B (facilities), surgical treatment is restricted to 
comprehensive cancer treatment centers. This is defined as cen-
ters having both surgical and radiotherapy facilities on site inde-
pendent of volume. From the patient perspective, it is desirable 
when the major treatment options (eg surgery and radiotherapy) 
are available in the same center. Furthermore, comprehensive 
cancer centers provide all necessary support services for the 
management of patients (eg andrology services).
In Scenario C (capacity utilization), prostate cancer sur-
gery is restricted to centers classified as “winners.” A pre-
vious analysis has demonstrated that patient choice has an 
impact on market share, creating “winners” and “losers” with 
some centers having a net gain of patients due to patient se-
lection and others a net loss.16 Closing centers that have a 
net-loss of patients to alternative centers could be considered 
to be a direct response to choices that patients seemed to have 
made themselves.
2.3 | Centralization simulation analysis
Simulation analysis was conducted to assess the impact of 
centralization of prostate cancer surgery services on patient 
travel times. After simulating the closure of a number of can-
cer surgery centers, the probability of travelling to each of 
the remaining centers in the choice set was predicted for all 
individual patients, using a conditional logit choice model.33 
Similar to other studies26 we restricted patient choice sets to 
reduce the computational burden as well as to avoid a poten-
tial bias caused by outliers. That is, choice sets included all 
prostate cancer surgery centers within 3 hours of travel time 
(which is about eight times patients’ median travel time for 
prostatectomy in the English NHS).
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In addition to travel time from the patient's home to the 
prostate cancer surgery center, we included three center-level 
characteristics: established robotic center, university teaching 
hospital, and strong media reputation. These were informed 
by a previous systematic review of the literature and qualita-
tive interviews with both men previously treated for prostate 
cancer and uro-oncology specialists currently practicing in the 
UK.13,28,34 A previous analysis has also demonstrated that men 
had greater odds of travelling to a center with one of these char-
acteristics for prostate cancer surgery, independent of travel 
time, with one in three men bypassing their nearest center.13
We also included five patient characteristics: elderly 
(≥65 year), comorbidity, socioeconomic background and res-
idence (residing in urban or rural area as well as residing in 
London or not). These characteristics were included as inter-
action terms with travel time in the conditional logit choice 
model.
Changes in travel burden resulting from centralization of 
surgery services were calculated as the difference between 
actual times travelled by patients for their radical prostatec-
tomy precentralization and weighted average travel times 
postcentralization. The choice probabilities predicted by the 
conditional logit model were used as weights reflecting the 
relative importance of the remaining cancer centers to the 
patient. To compare this new simulation approach with the 
distance minimization approach used by previous simulation 
studies in this field of research, we also estimated the travel 
burden by assigning patients to their nearest available center 
postcentralization.
To study what the impact on travel time of closing cancer 
centers is according to patient characteristics, we estimated a 
multivariable linear regression model with change in travel 
burden as the dependent variable and the five patient charac-
teristics as explanatory variables. In addition, pre- and post-
centralization average travel times are presented graphically 
for different patient groups to illustrate increased inequities 
in treatment access. All analyses were undertaken in Stata 
version 14.
3 |  RESULTS
3.1 | Patient sample and centralization 
scenarios
We studied 19,256 patients who were diagnosed with prostate 
cancer between January 2010 and December 2014, and who 
subsequently underwent a radical prostatectomy in the English 
NHS. We excluded 211 (1%) men who went to a cancer center 
more than 3 hours away from their home address as well as 16 
men (0.1%) who had only one provider option within 3 hours.
The final sample was composed of 19,029 men living in 
England matched to 65 providers of prostate cancer surgery. 
Among the patients, 8046 (42%) were aged 65 and over, 1422 
(7%) had at least one comorbidity, and 9064 (48%) lived in 
the most socio-economically deprived areas (Table 1). In the 
sample, 4442 men (23%) lived in rural areas and 2656 (14%) 
in London. On average, patients travelled 31 minutes to their 
treatment center. For each scenario, the hypothetical closures 
of surgical units are represented in Figure 1. Table 1 presents 
the descriptive statistics of these patient subgroups as well as 
the total patient group.
The number of patients affected by the centralization dif-
fers across scenarios. Under scenario A (volume), in which 
T A B L E  1  Sociodemographic characteristics of patients in centers that closed according to the centralization scenario
Total patient 
cohort Scenario A (volume) Scenario B (facilities)
Scenario C (capacity 
utilization)
65 centers 28 centers closing 24 centers closing 37 centers closing
19,029 patients 
included
3993 patients moving to 
another center
5763 patients moving 
to another center
7896 patients moving 
to another center
Number (%) Number (%) Number (%) Number (%)
Aged 65 and over 8046 (42) 1689 (42) 2380 (41) 3302 (43)
Low socioeconomic status 
(national IMD quintiles 3-5)
9064 (48) 1959 (49) 2797 (49) 3847 (50)
At least one comorbidity 1422 (7) 285 (7) 464 (8) 511 (7)
Place of residence
Rural area 4442 (23) 1041 (26) 1021 (18) 1808 (24)
London 2656 (14) 247 (6) 637 (11) 778 (10)
Other urban areaa 11,931(63) 2705 (68) 4105 (71) 5073 (66)
Note: Values are numbers with percentages in parentheses.
aResidence in an urban area, but not in London. 
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28 centers (43%) performing <50 prostatectomies per year 
are closed, 3993 men (21% of the total patient group be-
tween 2010 and 2014) would have to choose a new treatment 
location.
A total of 5763 men (30%) would be affected by cen-
tralization scenario B (facilities), in which prostate cancer 
surgical treatment is restricted to 41 comprehensive cancer 
treatment centers and 24 (37%) centers are closed.
Under scenario C (capacity utilization), in which 37 cen-
ters (57%) identified as having a net loss of patients are closed, 
7896 men (41%) would reselect treatment location. Under 
this latter scenario, 237 men (3%) would have no alternative 
cancer center available within 3 hours of travel time. Their 
average travel time would increase from 50 to 213 minutes if 
they travelled to the nearest available center postcentraliza-
tion. For this very small group of men we did not calculate 
weighted average travel times postcentralization because, as 
explained above, an underlying assumption of the estimated 
choice model is that patient choice sets only include cancer 
surgery centers within 3 hours of travel time.
3.2 | Patient preferences
Table 2 reports the estimation results of the conditional logit 
choice model. Patients preferred to have surgery in a center 
requiring shorter travel time (odds ratio < 1). There are sta-
tistically significant differences in the impact of travel time 
between patient groups at the 1% level. The impact of travel 
time was greater in men from a socioeconomically more de-
prived area (national IMD quintiles 3-5) than in men living 
in more affluent areas. This is demonstrated by the odds ratio 
of <1, indicating men from lower socioeconomic areas had 
a lower willingness to travel. The impact of travel time was 
also greater in men aged 65 and over, in men with comor-
bidity, and in men living in London and other urban areas. 
They had a lower willingness to travel (odds ratios < 1) than 
younger (<65), fitter (no comorbidities) men and those liv-
ing in rural areas. Individuals also preferred to be treated in 
centers that provide robotic prostate cancer surgery and in 
centers that employ surgeons with a strong media reputation 
as demonstrated in a previous analysis.13
3.3 | Impact of centralization on travel time
For each centralization scenario there is a substantial increase 
in the expected patient travel time using the estimated con-
ditional logit choice model (Figure 2, orange bars). Patients 
affected by the centralization in scenario A had to travel an 
additional 28  minutes on average with postcentralization 
average travel time approaching 1 hour. Hence, travel time 
would more than double (108% relative increase) on aver-
age for them. Under centralization scenario B the additional 
travel time for the affected patients would be on average 
15 minutes (+63%). Finally, in centralization scenario C, pa-
tients reselecting their treatment location would be expected 
to travel an additional 32 minutes (+133%).
Figure  2 also considers what happens if patients are di-
verted to their next nearest center (distance minimization ap-
proach). As expected, the increase in average patient travel 
time for those affected by centralization is consistently less 
with this approach compared to the simulation approach which 
considers patients’ preferences. For example, patients would 
have to travel 22 more minutes (+85%) on average under sce-
nario A if they would go to the next nearest center compared 
to 28 more minutes if they would travel to a center according 
to the predictions of the conditional logit choice model.
F I G U R E  1  Location of open and closed prostate cancer surgery centres for each hypothetical centralisation scenario
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3.4 | Impact of centralization on inequities 
in access
Table 3 demonstrates the results of the multivariable linear 
regression analysis examining the average impact of each 
centralization scenario on specific patient groups’ travel 
time. In each scenario, as shown by the results for the base 
case patient, there is a significant increase in patient travel 
burden ranging from 16 minutes in scenario B to 30 minutes 
in scenario C.
For patients from London the increase in travel time is 
much less than for patients living in a rural area. For example, 
under scenario C the average increase in patient travel time 
for London dwellers is 23 minutes less, all else being equal.
OR
95% confidence 
interval
P-
value
Travel time (in minutes) for base case patienta 0.920 0.918 to 0.922 <0.001
Interaction with patient characteristica 
×Age ≥ 65 0.991 0.989 to 0.994 <0.001
×Low socioeconomic status (IMD score 3-5) 0.996 0.994 to 0.999 0.003
×At least one comorbidity 0.987 0.981 to 0.992 <0.001
×London (compared to other Urban area) 0.846 0.837 to 0.854 <0.001
×Rural area (compared to other Urban area) 1.021 1.018 to 1.023 <0.001
Strong media reputation 1.933 1.841 to 2.028 <0.001
University-teaching hospital 0.928 0.889 to 0.970 0.001
Established robotic center 1.756 1.655 to 1.862 <0.001
N observations 505,045
N patients 19,029
aThe base case patient represents an individual with the following characteristics: Age < 65, socioeconomic 
status—high (IMD 1-2), No comorbidities, living in an Urban area (not London). The impact of the patient 
characteristics on travel time is presented as interaction terms. These should be multiplied with the adjusted 
OR for “travel time” for the base case patient (0.920) to formulate a new OR. Interaction terms can be used 
in any combination to assess the effect of different patient characteristics on the odds that a patient travels to 
a particular hospital. As an example, to calculate the new OR for an elderly man (age ≥ 65), with at least one 
comorbidity, living in London, but still of high socioeconomic status—multiply 0.920 by the corresponding 
interaction term for men who are elderly (0.991), have comorbidity (0.987) and who live in London (0.846). 
The new odds ratio is 0.920 × 0.991 × 0.987 × 0.846 = 0.761. Men with this sociodemographic profile have a 
lower willingness to travel than the base case patient described. 
T A B L E  2  Odds ratios (OR) from the 
conditional logit choice model estimating 
the probability of travelling to one of the 
prostate cancer surgery centers available 
within 3 h
F I G U R E  2  Average time travelled 
pre-centralisation and average travel time 
expected postcentralisation in minutes for 
scenarios A (volume), B (facilities), and C 
(capacity utilisation)
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Under scenarios A and C, for patients living in rural 
areas the increase in travel time is higher than for patients 
living in urban areas. The biggest impact is noted in sce-
nario C (+15  minutes compared to patients from urban 
areas).
All three centralization scenarios would result in a very 
small decrease in travel times for older patients (>65 years 
old) compared to their younger counterparts, although this 
was only statistically significant for scenario B (average 
adjusted difference of −1.5 minutes). For patients with at 
least one recorded comorbidity, scenario A results in a sig-
nificantly higher but very marginal increase in travel time 
(average adjusted difference +2.8  minutes) compared to 
patients with no comorbidity. For patients from less afflu-
ent areas (IMD score 3-5), both scenario B and C result in 
a significantly higher but very small increase in travel time 
(average adjusted differences of +1.3 and +1.7  minutes, 
respectively) compared to those living in more affluent 
areas.
The model enables an evaluation of men with different 
patient characteristics (Table  3). For example, under sce-
nario C a man of lower socioeconomic status living in a 
rural area would have to travel an additional 46.7  minutes 
(30.19 + 15.08 + 1.70) compared to an additional 13.4 min-
utes (30.19 − 1.70) for an affluent man living in an urban 
area.
Appendices S1-S3 present the variation in impact of the 
three centralization scenarios across different patient groups, 
based on combinations of different characteristics that have 
been found to be statistically significant from the multivari-
able regression analyses as presented in Table 3.
4 |  DISCUSSION
This study provides an innovative simulation approach for 
assessing the impact of centralizing complex cancer surgery 
services on patients’ travel burden. Using individual patient-
level data on all men who underwent radical prostatectomy 
in the English NHS between 2010 and 2014, we considered 
three pragmatic scenarios for centralization of prostate can-
cer surgery services: scenario A (volume), scenario B (facili-
ties), and scenario C (capacity utilization).
Compared to previous studies in this field of research, our 
approach explicitly takes into account patients’ preferences 
revealed through their actual hospital selections by using data 
on patient visits from administrative patient datasets to model 
patient choice. Travel times postcentralization are calculated 
as a weighted average of travel times to remaining cancer cen-
ters using the probabilities predicted by an estimated condi-
tional logit choice model as weights. Our approach therefore 
results in more realistic predictions than previous studies that 
simply assumed that patients affected by centralization would 
go to their nearest alternative center that would be still open.
For each of the centralization scenarios an overall increase 
in average travel burden is apparent, with the smallest impact 
found for scenario B (+15 minutes) and the biggest impact 
found for scenarios A (+28 minutes) and C (+32 minutes). 
Different scenarios have a different overall impact on (aver-
age) travel time and therefore on equity given the reduced 
willingness to travel of older, sicker, and lower socioeco-
nomic groups. Of note, particularly under scenario C, extra 
travel time substantially differs according to whether patients 
live in rural or an urban area.
T A B L E  3  Impact of different centralization scenarios on travel time according to patient characteristics. Results of multivariable regression
Scenario A (volume) Scenario B (facilities)
Scenario C (capacity 
utilization)
3993 patients 5763 patients 7659 patients
Increase in travel time (95% CI) (min)
Increase in travel time for 
base case patienta 
29.10 (27.75 to 30.45) P < 0.001 16.46 (15.44 to 
17.49)
P < 0.001 30.19 (29.10 to 
31.28)
P < 0.001
Difference in increase in travel time compared to base case patient
Age ≥ 65 −0.74 (−2.23 to 0.76) P = 0.334 −1.46 (−2.60 
to − 0.33)
P = 0.012 −0.05 (−1.22 to 
1.13)
P = 0.940
Low socioeconomic 
status (IMD score 3-5)
−0.80 (−2.30 to 0.69) P = 0.292 1.32 (0.17 to 2.46) P = 0.024 1.70 (0.52 to 2.87) P = 0.005
At least one comorbidity 2.86 (0.00 to 5.73) P = 0.050 −1.10 (−3.16 to 
0.95)
P = 0.293 −0.73 (−3.06 to 
1.60)
P = 0.538
London (compared to 
other Urban area)
−23.25 (−26.36 
to − 20.13)
P < 0.001 −12.96 (−14.78 
to − 11.14)
P < 0.001 −22.69 (−24.66 
to − 20.73)
P < 0.001
Rural (compared to other 
Urban area)
4.31 (2.62 to 6.01) P < 0.001 0.47 (−1.03 to 
1.97)
P = 0.539 15.08 (13.68 to 
16.47)
P < 0.001
aThe base case patient represents an individual with the following characteristics: Age < 65, socioeconomic status—high (IMD 1-2), no comorbidities, living in an 
Urban area (not London). 
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The results provide more general insights into the impli-
cations of a program of surgical service centralization on 
predicted travel burden, equity, and efficiency of the service. 
First, the use of a pure distance minimization approach in un-
derstanding travel burden on patients would not fully capture 
the impact of a patient's own personal characteristics and per-
sonal preferences for particular hospital characteristics. This 
is relevant in the context of the NHS and other health systems 
supporting patient choice.28
Second, the use of national rather than regional datasets 
provides a clear understanding on the differential impact of 
national top-down policies on travel burden. Specifically, 
uniform policy criteria, disproportionately affect patients 
living in rural areas, who on average have to travel sig-
nificantly further compared to those living in urban areas, 
which demonstrates the difficulties of “one size fits all” 
centralization policies. This is most clearly observed in 
Scenario C with its increases in travel time especially for 
patients in rural areas. This may result in lower utilization 
of curative and palliative treatments, creating regional in-
equities in outcomes.
Conversely, one can see how such mechanisms for 
service re-design may have a negligible impact on travel 
burden for patients in highly urbanized regions such as 
London. In these settings, the capacity of centers to expand 
their service would be the next criteria to consider. One 
caveat with our current approach is the use of private drive 
times alone as public transport times were not available. 
This could impact on the observed differences and behav-
iors, in the different regions.
Third, in addition to the overall increase in travel time 
which is likely to be more problematic for vulnerable patient 
groups, it was noted that patients’ personal characteristics (eg 
socioeconomic status) could affect equity in access gradients 
further. All three centralization scenarios result in an increase 
in travel time for patients, however, the extra travel burden 
on specific patient groups resulting from these centralization 
scenarios is in reality very small.
Fourth, scenarios A and B result in similar numbers of can-
cer surgical unit closures (28 and 24 respectively), but very 
different impacts on patient travel burden that can inform pol-
icy. The findings suggest that efficiencies could be achieved 
by closing noncomprehensive cancer centers (scenario B), as 
the expected average increase in travel burden of 15 minutes is 
almost half that expected from Scenario A (28 minutes). The 
closure of centers in scenario B could result in increases in the 
number of procedures performed at the remaining 41 centers 
assuming demand remains the same, and hence the objectives 
for A (creating high volume radical prostatectomy centers) 
and B (ensuring each cancer center is a comprehensive cancer 
center) may be achievable through a single policy.
Scenario C, considers a different scenario, whereby 
centers, that are “losing” patients to other centers should 
be closed given preferences for alternative centers. Hence, 
patients through their choices and that of their primary 
care physicians, can influence which services remain open. 
However, the impact on patients with respect to travel burden 
is significant, particularly for rural dwellers, who face addi-
tional travel times of up to 45 minutes. The map in Figure 1C, 
shows that surgical units expected to close under this sce-
nario would cover substantial catchment areas (eg Cornwall, 
Devon, Norfolk, Kent, Cumbria) where few alternative cen-
ters are available and patients experience a significant travel 
burden in accessing local services. In addition, this could 
have a detrimental impact on access to specialist care. It also 
informs us that, within the NHS, a capacity maximization ap-
proach is unlikely to be achievable given the need to ensure 
equitable access nationally. Hence, centers may continue to 
operate despite having surplus capacity to protect access.
Although the simulation approach presented in this paper 
used data from a single-payer health system, it is certainly 
adaptable across different contexts. Our study shows how 
the impact of centralization options can be empirically in-
vestigated if relevant patient data are available. Our meth-
odological approach can be further developed to incorporate 
information on hospital quality and patient outcomes; for 
example, rates of toxicity at the provider-level for patients 
undergoing radical prostatectomy.35 One can then model the 
effect of changes in provider-level quality on willingness to 
travel, and how this varies between different patient groups 
as previously described.36 With respect to travel burden, it 
is not just travel time or distance that needs to be considered 
but also its cost to the patient. In addition, where provision of 
surgery and radiotherapy is not at a single site, the differential 
impact of the closure of such a site on the uptake of each of 
these treatment modalities can be considered.37
Further simulations could estimate the expected improve-
ments or worsening of patient outcomes that may result from 
centralization. In this way we can observe directly the trade-
offs between travel times, equity, and quality, which need to 
be considered with health service planning.25 This model-
ing approach could also be used to fit the k best centers to 
close, such that differences between population groups and/
or headline travel times are minimized. This would present 
an a-theoretic, data driven comparator to the top-down policy 
approach simulated here.
5 |  CONCLUSION
In this paper, we present an innovative simulation ap-
proach using national patient-level datasets to understand 
better the impact of service re-design on patient travel 
burden and equity in access to services. Our study results 
show how in the English NHS the additional travel bur-
den associated with unit closures is regionally patterned 
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and can widen inequities in access for particular patient 
groups, particularly those living in rural areas. Equally it 
also demonstrates, how in certain scenarios, quite signifi-
cant centralization of the service, with closure of just over 
one-third of current centers (24 of 65 centers), may result 
in only a relative small impact on patients with respect to 
travel time. Future work should focus on better understand-
ing the trade-offs between equity, travel burden, and pa-
tient outcomes to inform health care services re-design. In 
this regard, we expect the model to be applicable to other 
tumor types and specialist disciplines.
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